Cargando…

Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients

BACKGROUND: Acute rejection (AR) episodes in renal transplant recipients are suspected when plasma creatinine is elevated and other potential causes out ruled. Graft biopsies are however needed for definite diagnosis. Non-invasive AR-biomarkers is an unmet clinical need. The urinary proteome is an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loftheim, Håvard, Midtvedt, Karsten, Hartmann, Anders, Reisæter, Anna V, Falck, Pål, Holdaas, Hallvard, Jenssen, Trond, Reubsaet, Leon, Åsberg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561036/ https://www.ncbi.nlm.nih.gov/pubmed/23369437 http://dx.doi.org/10.1186/2047-1440-1-9

Ejemplares similares

Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022)

Should patients older than 65 years be offered a second kidney transplant?
por: Heldal, Kristian, et al.
Publicado: (2017)

One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
por: Dörje, Christina, et al.
Publicado: (2015)

Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival
por: Witczak, Bartlomiej J., et al.
Publicado: (2021)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
por: Blom, Kjersti B., et al.
Publicado: (2023)

Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020)

Increased risk of ischaemic heart disease after kidney donation
por: Haugen, Anders J, et al.
Publicado: (2021)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
por: Bremer, Sara, et al.
Publicado: (2009)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
por: Onsøien, Mari O., et al.
Publicado: (2021)

Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023)

Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
por: Pihlstrøm, Hege Kampen, et al.
Publicado: (2020)

Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
por: Ussif, Amin M., et al.
Publicado: (2019)

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
por: Ussif, Amin, et al.
Publicado: (2018)

Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
por: Langberg, Nina Elisabeth, et al.
Publicado: (2021)

Inflammation in the early phase after kidney transplantation is associated with increased long‐term all‐cause mortality
por: Heldal, Torbjørn Fossum, et al.
Publicado: (2022)

A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
por: Jørgensen, Hanne Skou, et al.
Publicado: (2021)

Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study
por: Heldal, Torbjørn F., et al.
Publicado: (2023)

Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
por: Lønning, Kjersti, et al.
Publicado: (2018)

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
por: Lønning, Kjersti, et al.
Publicado: (2016)

Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients
por: Pihlstrøm, Hege, et al.
Publicado: (2014)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
por: Blom, Kjersti B., et al.
Publicado: (2021)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
por: Drevland, Ole Martin, et al.
Publicado: (2023)

Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
por: Heldal, Kristian, et al.
Publicado: (2013)

Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients
por: Robertsen, Ida, et al.
Publicado: (2013)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
por: Nordheim, Espen, et al.
Publicado: (2016)

Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
por: Gustavsen, Marte Theie, et al.
Publicado: (2020)

Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
por: Åsberg, Anders, et al.
Publicado: (2013)

Importance of hematocrit for a tacrolimus target concentration strategy
por: Størset, Elisabet, et al.
Publicado: (2013)

Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma
por: Rollag, Halvor, et al.
Publicado: (2013)

Kidney-transplanted Adolescents—Nonadherence and Graft Outcomes During the Transition Phase: A Nationwide Analysis, 2000–2020
por: Kindem, Ingvild A., et al.
Publicado: (2023)

Health-Related Quality of Life in Older Kidney Transplant Recipients: A National Cohort Study of Short- and Longer-Term Outcomes
por: Tsarpali, Vasiliki, et al.
Publicado: (2021)

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients—A Cross-Validation Study
por: Kindem, Ingvild Andrea, et al.
Publicado: (2021)

Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool – a retrospective study
por: Haller, Maria C., et al.
Publicado: (2020)

Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone
por: Lindahl, Jørn Petter, et al.
Publicado: (2022)

Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
por: Salvador, Cathrin L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ccuhms1f6d17vmrfokpc4h0l00